Gwan-Su Yi (Gwansu Yi)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Gene Expression

Top Venues

International journal of molecular sciences

Life (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Young-Sun Lee, Osung Kwon, Geuk-Rae Jeong, Junyeol Noh, Sung Eun Kim, Gwan-Su Yi, Eun Mi Hwang, Jae-Yong Park
Deficiency of TTYH1 Expression Reduces the Migration and Invasion of U2OS Human Osteosarcoma Cells. Life (Basel, Switzerland) 12 (4) (2022)
Seongyong Park, Gwan-Su Yi
Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer. Cancers 14 (4) (2022)
Joo Yeon Jeong, Haangik Park, Hong Yoo, Eun-Jin Kim, Borami Jeon, Jong Deog Lee, Dawon Kang, Changjoon Justin Lee, Sun Ha Paek, Eun Joo Roh, Gwan-Su Yi, Sang Soo Kang
Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment. Biomedicines 10 (5) (2022)
Maryam Yavartanoo, Gwan-Su Yi
Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification. International journal of molecular sciences 22 (21) (2021)
Yoon Hyeok Lee, Gwan-Su Yi
Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking. International journal of molecular sciences 19 (10) (2018)